CDKN2A (also known as P14ARF or P16INK4A) is a G1-S cell cycle regulator and tumor repressor, the loss-of-function mutations and epigenetic inactivation of which have been observed in various cancer types, including HCC (8, 9). Here, CDKN2A is linked to hepatocellular carcinoma.